CGEN
Price
$1.42
Change
-$0.01 (-0.70%)
Updated
Sep 3 closing price
Capitalization
134.25M
63 days until earnings call
ROIV
Price
$12.59
Change
+$0.20 (+1.61%)
Updated
Sep 3 closing price
Capitalization
8.59B
74 days until earnings call
Interact to see
Advertisement

CGEN vs ROIV

Header iconCGEN vs ROIV Comparison
Open Charts CGEN vs ROIVBanner chart's image
Compugen
Price$1.42
Change-$0.01 (-0.70%)
Volume$113.37K
Capitalization134.25M
Roivant Sciences
Price$12.59
Change+$0.20 (+1.61%)
Volume$10.39M
Capitalization8.59B
CGEN vs ROIV Comparison Chart in %
Loading...
CGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ROIV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CGEN vs. ROIV commentary
Sep 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CGEN is a Hold and ROIV is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 04, 2025
Stock price -- (CGEN: $1.42 vs. ROIV: $12.59)
Brand notoriety: CGEN and ROIV are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CGEN: 53% vs. ROIV: 198%
Market capitalization -- CGEN: $134.25M vs. ROIV: $8.59B
CGEN [@Biotechnology] is valued at $134.25M. ROIV’s [@Biotechnology] market capitalization is $8.59B. The market cap for tickers in the [@Biotechnology] industry ranges from $101.69B to $0. The average market capitalization across the [@Biotechnology] industry is $1.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CGEN’s FA Score shows that 1 FA rating(s) are green whileROIV’s FA Score has 0 green FA rating(s).

  • CGEN’s FA Score: 1 green, 4 red.
  • ROIV’s FA Score: 0 green, 5 red.
According to our system of comparison, ROIV is a better buy in the long-term than CGEN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CGEN’s TA Score shows that 4 TA indicator(s) are bullish while ROIV’s TA Score has 4 bullish TA indicator(s).

  • CGEN’s TA Score: 4 bullish, 4 bearish.
  • ROIV’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both CGEN and ROIV are a good buy in the short-term.

Price Growth

CGEN (@Biotechnology) experienced а -3.40% price change this week, while ROIV (@Biotechnology) price change was +5.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.29%. For the same industry, the average monthly price growth was +15.06%, and the average quarterly price growth was +30.89%.

Reported Earning Dates

CGEN is expected to report earnings on Nov 06, 2025.

ROIV is expected to report earnings on Nov 17, 2025.

Industries' Descriptions

@Biotechnology (+0.29% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ROIV($8.59B) has a higher market cap than CGEN($134M). CGEN has higher P/E ratio than ROIV: CGEN (60.33) vs ROIV (1.97). ROIV YTD gains are higher at: 4.734 vs. CGEN (-7.190). CGEN has higher annual earnings (EBITDA): -19.81M vs. ROIV (-1.18B). ROIV has more cash in the bank: 4.5B vs. CGEN (93.9M). CGEN has less debt than ROIV: CGEN (2.97M) vs ROIV (99.7M). ROIV (23.2M) and CGEN (22.1M) have equivalent revenues.
CGENROIVCGEN / ROIV
Capitalization134M8.59B2%
EBITDA-19.81M-1.18B2%
Gain YTD-7.1904.734-152%
P/E Ratio60.331.973,069%
Revenue22.1M23.2M95%
Total Cash93.9M4.5B2%
Total Debt2.97M99.7M3%
FUNDAMENTALS RATINGS
CGEN: Fundamental Ratings
CGEN
OUTLOOK RATING
1..100
8
VALUATION
overvalued / fair valued / undervalued
1..100
73
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
82
P/E GROWTH RATING
1..100
28
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CGENROIV
RSI
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 2 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 2 days ago
69%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 2 days ago
64%
MACD
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 2 days ago
65%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 2 days ago
63%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 2 days ago
63%
Advances
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 8 days ago
71%
Declines
ODDS (%)
Bearish Trend 14 days ago
90%
Bearish Trend 6 days ago
72%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 2 days ago
66%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
CGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ROIV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
ARVR48.02N/A
N/A
First Trust Indxx Metaverse ETF
LFAF120.49N/A
N/A
LifeX 2049 Longevity Income ETF
WLTG33.15-0.16
-0.48%
WealthTrust DBS Long Term Growth ETF
QQXT97.83-0.53
-0.54%
First Trust NASDAQ-100 ex-Tech Sect ETF
PPIE26.91-0.33
-1.20%
Putnam PanAgora ESG Intl Eq ETF

CGEN and

Correlation & Price change

A.I.dvisor indicates that over the last year, CGEN has been loosely correlated with BDTX. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if CGEN jumps, then BDTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CGEN
1D Price
Change %
CGEN100%
-0.70%
BDTX - CGEN
44%
Loosely correlated
+2.86%
ROIV - CGEN
40%
Loosely correlated
+1.61%
AUTL - CGEN
38%
Loosely correlated
+2.13%
IPSC - CGEN
38%
Loosely correlated
-1.60%
MLTX - CGEN
38%
Loosely correlated
+1.61%
More

ROIV and

Correlation & Price change

A.I.dvisor indicates that over the last year, ROIV has been loosely correlated with IMVT. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if ROIV jumps, then IMVT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ROIV
1D Price
Change %
ROIV100%
+3.86%
IMVT - ROIV
60%
Loosely correlated
+2.59%
ACLX - ROIV
54%
Loosely correlated
+0.52%
CRNX - ROIV
53%
Loosely correlated
+7.45%
KYMR - ROIV
51%
Loosely correlated
-1.24%
RVMD - ROIV
50%
Loosely correlated
+4.11%
More